Direct answer: Regulation (EU) 2025/40 on packaging and packaging waste, PPWR for short, has generally applied since 12 August 2026. It covers almost all packaging on the EU market, regardless of material, origin and distribution channel. Targeted exemptions exist for medicinal products and certain medical devices. However, they do not exempt companies across the board from packaging, documentation or disposal obligations. Manufacturers, importers, wholesalers, pharmacies and online retailers should therefore review each packaging level and their own role separately.
The PPWR takes effect in stages. Some obligations already apply; further requirements on labelling, recyclability, recycled content, empty space and reuse follow from 2028 and 2030 respectively. For the year-end business and packaging planning for 2027, now is the right time to sort out responsibilities, supplier documentation and packaging data.
What changed on 12 August 2026?
The PPWR has largely replaced the former Packaging Directive and creates directly applicable EU rules. It covers sales, grouped, e-commerce and transport packaging as well as their components. These can include, for example, bottles, blisters, folding cartons, labels, shipping boxes, cushioning material and films.
Since the date of application, companies must clarify, among other things, whether they act as packaging manufacturer, importer, distributor, fulfilment service provider or as a “producer” within the meaning of extended producer responsibility for a particular packaging. These terms are not identical. The manufacturer of the filled product is therefore not automatically the manufacturer of every packaging used; in cross-border sales, additional EPR obligations may arise in the country of destination.
The European Commission expressly points out that implementation is taking place step by step. Since August 2026, for example, the restriction of PFAS above set limit values in food contact packaging has also applied. Harmonised sorting labels will generally follow from 12 August 2028 or 24 months after the relevant implementing acts enter into force, whichever is later. Key design, recycled content and empty space requirements take effect from 2030.
The most important distinction: product category and packaging level
The most common misconception is: “Pharmaceutical packaging is exempt.” In fact, the PPWR contains several narrowly defined exemptions that relate to specific requirements and types of packaging. What matters is the product category, contact with the product, the function of the packaging and the specific statutory exemption.
Human and veterinary medicinal products
Targeted exemptions exist for immediate packaging and for necessary outer packaging, including with regard to recyclability, recycled content and labelling. The conditions must be documented; there is no complete exemption from the PPWR.
Medical devices and in vitro diagnostic medical devices
Certain contact-sensitive packaging is exempt from individual requirements. Here, too, the specific packaging and not just the product name is decisive.
Food supplements
They are foods and do not automatically fall under the exemptions for medicinal products. An exemption for plastic food contact packaging can only apply under the statutory conditions, for example if recycled content would endanger health or breach food contact law.
Cosmetics
The pharmaceutical exemptions do not apply simply because a product is sold through pharmacy-type channels. Primary and secondary packaging must be assessed according to the general PPWR rules and the relevant product-specific regulations.
E-commerce and transport packaging
Shipping boxes, filling material, stretch film and transport containers are separate packaging formats. An exemption for the immediate packaging of a medicinal product does not automatically extend to logistics packaging.
Which exemptions for medicinal products are particularly relevant?
1. Recyclability
Under Article 6, packaging is to be recyclable; the detailed design-for-recycling criteria and performance grades become relevant from 2030. Exemptions include immediate packaging of human and veterinary medicinal products that is in direct contact with the medicinal product. Outer packaging may also be exempt if it is necessary to meet specific requirements for preserving the quality of the medicinal product.
The exemption should not be applied across the board to every folding carton. The file should record in a traceable way why the specific packaging is necessary for quality, stability, tamper protection or safe use.
2. Recycled content in plastic
From 2030, minimum shares of recycled plastic will apply in stages. The PPWR exempts certain pharmaceutical and medical packaging, including immediate plastic packaging of medicinal products and certain quality-relevant outer packaging. For food supplements, by contrast, there is no general exemption. For food contact applications, it must be checked whether and to what extent authorised recycling technologies and food law safety requirements allow the use of recycled content.
3. Harmonised labelling
The future EU label is intended to make material composition and correct waste sorting easy to understand. Immediate and outer packaging of medicinal products and certain medical devices may be exempt from labelling if there is no space because of other mandatory information or if the additional label could jeopardise safe use.
This exemption is not a general design decision either. Companies should document the space check, mandatory information and risk assessment together.
What do manufacturers, importers and distributors need to do now in practice?
Build a packaging register per article
A robust register should record each packaging level separately: primary packaging, secondary packaging, label, package leaflet, shipping packaging and transport aids. Useful fields include material, weight, supplier, article or drawing number, food contact, product contact, single-use or reusable, target markets, EPR scheme and the exemption assumed, with its legal basis.
Define roles and responsibilities
For each format, it must be clarified who manufactures the packaging, imports it into the EU, markets it under their own name or makes it available on the target market for the first time. For EPR obligations, it must also be determined who counts as the producer in the respective member state. For private labels, contract manufacturing, parallel imports, marketplace business and dropshipping, responsibility may lie elsewhere than in conventional domestic business.
Request technical documentation
Packaging manufacturers must assess conformity and draw up an EU declaration of conformity; importers and distributors have their own verification and cooperation obligations. The technical documentation should contain specifications, material structure, tests, relevant standards, supplier declarations and the justification for exemptions. Under the PPWR, documents must generally be kept for five years for single-use packaging and ten years for reusable packaging.
Continue to meet national EPR obligations
The PPWR does not replace practical participation in national collection and recovery schemes overnight. In Austria, the existing national requirements continue to apply insofar as they do not conflict with the PPWR. Companies must therefore continue to check which quantities of packaging they place on the market in Austria, who is the primary obligated party, whether scheme participation and licensing are required and which records or reports must be kept in the EDM (Austria’s electronic data management system).
Moreover, an exemption from the recyclability requirement does not automatically mean an exemption from EPR fees. Environmental financing obligations and technical packaging requirements must be checked separately.
Which deadlines should the industry plan for?
- Since 12 August 2026: PPWR generally applicable; review roles, conformity processes, EPR and substance restrictions that already apply.
- From 12 August 2028 or later: harmonised material and sorting labels, depending on the entry into force of the implementing acts.
- From 2030: among other things, recyclability performance grades, minimum recycled content for plastic, requirements for packaging minimisation and empty space, and numerous reuse targets.
- From 2035: additional requirements for recycling at scale and review of certain exemptions.
This timeline is a basis for planning but does not replace a review of the respective article and target market. Several detailed rules still depend on delegated and implementing acts. Specifications and approvals should therefore be versioned and updated regularly.
PPWR checklist for Q4 2026 and planning for 2027
- Record all packaging formats per article – including shipping and transport packaging.
- Determine the product category and packaging function.
- Assign the economic operator role and EPR responsibility for each EU target market.
- Collect material and weight data as well as current supplier declarations.
- Justify pharmaceutical or medical device exemptions for each packaging level.
- Align technical documentation and the EU declaration of conformity with the packaging supplier.
- Check Austrian scheme participation, licensing and EDM obligations.
- Include packaging changes for 2028 and 2030 in purchasing, artwork and inventory planning.
- Plan old stock and print runs so that later labelling changes can be implemented economically.
- Only use marketing claims such as “recyclable”, “environmentally friendly” or “sustainable” with robust evidence.
For food supplements, the packaging review belongs in the same product dossier as formulation, label and distribution. Our guide to distributing food supplements in Austria shows the other building blocks for market entry. An overview of support with product development, distribution and logistics can be found under Shanab Pharma services.
Frequently asked questions about the PPWR in the pharmaceutical market
Does the PPWR also apply to pharmacies?
Yes, insofar as a pharmacy makes packaging available on the EU market or fills, imports or uses packaging for shipping itself. The specific obligation depends on its role. When simply purchasing goods that are already packaged, distributor checks and the correct handling of its own shipping packaging are likely to be the main concerns.
Is packaging for medicinal products completely exempt?
No. There are targeted exemptions for certain requirements and packaging levels. EPR, documentation and general obligations may still apply.
Do the exemptions for medicinal products also apply to food supplements?
No. Food supplements are legally foods. A brown glass bottle, capsule jar or pharmacy-style presentation does not turn the product into a medicinal product.
Does every packaging design already have to be changed in 2026?
Not across the board. Many design and labelling obligations only take effect later and still depend on secondary legislation. Companies should, however, sort out data, roles and documentation now, because packaging development, stability testing, artwork approval and stock reduction can have long lead times.
Is a supplier declaration sufficient?
It is an important building block but does not replace your own review of roles and plausibility. The documents must match the specific packaging, version, material composition and intended use.
What applies when selling to several EU countries?
The technical PPWR requirements are harmonised throughout the EU. EPR registration, authorised representation, scheme participation and enforcement, however, remain heavily dependent on the country of destination in practice. Each sales market should therefore be recorded separately in a responsibility matrix.
Conclusion: don’t wait for 2030
The PPWR is not just a topic for the future. Since August 2026, companies have had to have a firm grip on their roles, packaging data, conformity documents and national EPR obligations. The upcoming deadlines increase the pressure to act even further. Building a structured packaging register now and documenting exemptions product by product avoids later artwork corrections, delivery delays and unnecessary duplication of work.
Shanab Pharma supports manufacturers and trading partners in structuring product data, market entry, distribution and logistics. Contact us with your product category, target markets and an overview of your packaging levels to discuss the next steps.
Sources and further information
- EUR-Lex: Regulation (EU) 2025/40 on packaging and packaging waste
- European Commission: Packaging waste – overview and implementation status
- European Commission, 11 August 2026: New EU packaging rules start to apply
- European Commission, 3 August 2026: FAQ on the PPWR
- European Commission: Guidance on Regulation (EU) 2025/40
- RIS: Austrian Packaging Ordinance 2014, current version (in German)
- Austrian Business Service Portal (USP): packaging – obligations for companies (in German)
- EDM: legal basis and relationship between the PPWR and Austrian obligations (in German)
Note: This article provides general guidance as of 26 October 2026 and does not constitute legal advice. The specific assessment depends on the product, packaging format, supply chain and target market.
